Invests in
Sectors:
Locations:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
Lists including Robert
Work Experience
2017
Director
2017
MBC BioLabs helps life-science startups be fast and efficient. Our state-of-the-art life-science incubator rents space as small as a single lab bench and has a core facility with everything a startup needs to generate data on day-one.
2017
Partner
2017
Mission Bay Capital uses capital and expertise to help entrepreneurial scientists change the world. MBC makes pivotal early-stage investments in life-science companies. Our focus is on helping startups efficiently resolve key technical risks. We accomplish this through our network of advisors, partners, and incubators.
2017
Partner
2017
Mission BioCapital brings together two U.S.-based early-stage life science venture firms: BioInnovation Capital and Mission Bay Capital. For years, we have shared the same experienced team and the same vision. Now, we share the same name and a deep excitement about the future of life science innovation.
2013 - 2017
Manager
2013 - 2017
Novozymes is a global biotechnology company headquartered in Bagsværd outside of Copenhagen, Denmark. At Novozymes we challenge traditional industrial thinking and ask the world to Rethink Tomorrow. Together, we find biological answers for better lives in a growing world. We know that many of the answers which the world needs can be found in some of the smallest things in nature: inside the cells.
2007 - 2013
CEO & President
2007 - 2013
Allopartis Biotechnologies was founded in 2007 to develop optimized biocatalysts for industrial enzymes and synthetic biology. Located in San Francisco's Mission Bay Innovation Corridor, Allopartis packs a lot of science into a small space. Using single-molecules, Allopartis scientists search for the very best enzymes by performing billions of reactions in parallel. Allopartis was acquired by Novozymes in 2013.